Potassium Carbonate → HCID 117777429, 화합물

HRID 64180

반응식

HRID 64180 반응식
Br[C:2]1[CH:31]=[CH:30][C:5]2[N:6]([C:9]3[CH:10]=[C:11]([NH:23][S:24]([CH:27]4[CH2:29][CH2:28]4)(=[O:26])=[O:25])[CH:12]=[C:13]([C:15]4[CH:20]=[CH:19][C:18]([F:21])=[CH:17][C:16]=4[F:22])[CH:14]=3)[CH:7]=[N:8][C:4]=2[CH:3]=1.C(=O)([O-])[O-].[K+].[K+].[CH2:38]([N:40]1[CH2:45][CH2:44][NH:43][CH2:42][CH2:41]1)[CH3:39].N1CCC[C@H]1C(O)=O>CS(C)=O.[Cu]I>[CH2:38]([N:40]1[CH2:45][CH2:44][N:43]([C:2]2[CH:31]=[CH:30][C:5]3[N:6]([C:9]4[CH:10]=[C:11]([NH:23][S:24]([CH:27]5[CH2:29][CH2:28]5)(=[O:26])=[O:25])[CH:12]=[C:13]([C:15]5[CH:20]=[CH:19][C:18]([F:21])=[CH:17][C:16]=5[F:22])[CH:14]=4)[CH:7]=[N:8][C:4]=3[CH:3]=2)[CH2:42][CH2:41]1)[CH3:39]

참가 물질

7

실험 절차

To a solution of the compound of N-(5-(5-bromo-1H-benzo[d]imidazol-1-yl)-2′,4′-difluoro-[1,1′-biphenyl]-3-yl)cyclopropanesulfonamide (110 mg, 0.198 mmol) in DMSO was added potassium carbonate (54 mg, 0.391 mmol, 2.0 eq.). The mixture was degassed by N2 bubbling for 10 min followed by addition of 1-ethylpiperazine (68 mg, 0.595 mmol, 3.0 eq.) and L-proline (4.5 mg) and CuI (3 mg). Then seal tube was closed and the mixture was kept at 95° C. for 24 h. The mixture was quenched and extracted as in Example 1(d). The solvent was distilled off to afford the crude residue which was purified by preparative HPLC to give the product in 18% yield (20 mg). 1H NMR (400 MHz, DMSO-D6): δ10.3 (s, 1H), 8.98 (s, 1H), 7.77 (m, 1H), 7.66 (s, 1H), 7.60 (brs, 2H), 7.50 (brs, 2H), 7.41 (s, 1H), 7.33-7.27 (m, 2H), 3.60 (m, 4H), 3.29-3.20 (m, 4H), 3.02 (q, 2H), 2.90 (t, 1H), 1.30 (t, 3H), 1.04 (q, 4H), LC-MS (ESI): Calculated mass: 537.62; Observed mass: 538.1 [M+H]+

후처리

  1. customThe mixture was degassed by N2 bubbling for 10 min
  2. customThen seal tube
  3. customwas closed
  4. customThe mixture was quenched
  5. extractionextracted as in Example 1(d)
  6. distillationThe solvent was distilled off

출처 및 근거

ORD 기록
ord-5c2d842e7c0f4712a8e85d08303f3378
출처 데이터셋
uspto-grants-2016_09
특허 번호
US09447091B2

연결된 노트

불러오는 중…